2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

Dan Eisenberg, Scott A. Shikora, Edo Aarts, Ali Aminian, Luigi Angrisani, Ricardo V. Cohen, Maurizio de Luca, Silvia L. Faria, Kasey P.S. Goodpaster, Ashraf Haddad, Jacques M. Himpens, Lilian Kow, Marina Kurian, Ken Loi, Kamal Mahawar, Abdelrahman Nimeri, Mary O’Kane, Pavlos K. Papasavas, Jaime Ponce, Janey S.A. PrattAnn M. Rogers, Kimberley E. Steele, Michel Suter, Shanu N. Kothari

Research output: Contribution to journalArticlepeer-review

145 Citations (Scopus)
10 Downloads (Pure)

Abstract

Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities. MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2. BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS. Long-term results of MBS consistently demonstrate safety and efficacy. Appropriately selected children and adolescents should be considered for MBS. (Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013)

Original languageEnglish
Pages (from-to)3-14
Number of pages12
JournalObesity Surgery
Volume33
Issue number1
Early online date7 Nov 2022
DOIs
Publication statusPublished - Jan 2023

Keywords

  • ASMBS
  • Criteria
  • IFSO
  • Indications
  • Metabolic and bariatric surgery
  • Obesity

Fingerprint

Dive into the research topics of '2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery'. Together they form a unique fingerprint.

Cite this